![Blood / Coagulation system / Peripheral membrane proteins / Von Willebrand disease / Coagulation / Factor IX / Bleeding / Clinical trial / Partial thromboplastin time / Haemophilia / Medicine / Health Blood / Coagulation system / Peripheral membrane proteins / Von Willebrand disease / Coagulation / Factor IX / Bleeding / Clinical trial / Partial thromboplastin time / Haemophilia / Medicine / Health](https://www.pdfsearch.io/img/ed2d6672b2be3eb9db3ffdbb122bca59.jpg)
| Open Document File Size: 801,77 KBShare Result on Facebook
City Philadelphia / / Company Administration Dosing Regimen Baxter Healthcare Corporation / Adobe / Baxter / / Country United States / / Event FDA Phase / / Holiday Christmas / / IndustryTerm Hemophilia care / manufacturing / perioperative management / / MedicalCondition hereditary / Christmas disease / Disease / von Willebrand's Disease / deficiency / dysfunction / hemophilia B. The / hemophilia B / Hemophilia / blood disorder / / Organization FDA / World Health Organization / Advisory Committee / Application Type STN CBER Received Date PDUFA Goal Date Division / / Person Stephanie O. Omokaro / / Position WB / Acrobat / / Product B / / ProvinceOrState Indiana / / PublishedMedium the Clinical Review / The AAPS Journal / the Art Review / / Technology pharmacokinetics / antibodies / Acrobat / / URL www.wfh.org / http /
SocialTag |